The impact of Cytogam [cytomegalovirus immune globulin] on time to viral load reduction in kidney or kidney/pancreas transplant recipient with clinical CMV [cytomegalovirus] disease
Phase of Trial: Phase III
Latest Information Update: 25 Jun 2012
At a glance
- Drugs Cytomegalovirus immune globulin (Primary) ; Ganciclovir
- Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
- Focus Therapeutic Use
- 25 Jun 2012 Actual patient number is 28 as reported by ClinicalTrials.gov.
- 25 Jun 2012 Actual end date (1 Apr 2007) added as reported by ClinicalTrials.gov.
- 25 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.